
UK Approves ‘Game-changing’ Drug For Advanced Breast Cancer Treatment
The United Kingdom’s National Institute for Health and Care Excellence (NICE) has approved a “game-changing” twice-daily pill that is said to slow the spread of an incurable type of breast cancer. The drug, Truqap, developed by AstraZeneca, targets the AKT protein, a molecule known to fuel the multiplication of cancer cells. By inhibiting AKT’s action,…